1⃣ £336m was raised in venture capital between December 2020 and February 2021, up from £123m in the same period a year ago
2⃣ £215m was raised through IPO, up from £0 a year ago
3⃣ £279m was raised through follow-on financings, up from £186m a year ago
2/4
Following on from a buoyant 2020, large later-stage rounds remain readily obtainable as investors, especially those from the US, continue to see the long-term potential of biotech.
3/4
Raising £336m, the UK biotech sector maintains its position in the global top five and accounted for almost 38% of total European biotech VC financing.🌎
4/4
• • •
Missing some Tweet in this thread? You can try to
force a refresh
New data published today by the BioIndustry Association and @clarivate reveals UK biotechs raised a total of £2.8bn in 2020, marking the best ever year for the sector.
Investment in UK #biotech has increased by over 1000% since 2012! 💰
2020’s £2.8bn record far exceeds the £2.2bn record set in 2018 and is over 10x the total raised in 2012, when the BIA began publishing #investment data. 2/5
UK biotechs raised a total of £1.39bn in venture capital funding over the last five years.📈 3/5
📢BIA report published today reveals that #biotech companies on London stock markets delivered market-beating returns in 2020 and attracted new #investors looking for growth in a turbulent year.
The combined share price of UK-quoted biotech companies was up 155% over the year.📈
It was outperforming the #FTSE All-Share before the #pandemic hit the UK and accelerated after. 2/7
Those involved in diagnostics and #COVID19 treatments were the best performers (up 493% and 475%, respectively).🧫
Other sub-sectors including small molecule drug development (+286%), research tools and data (+153%) and cell & gene therapies (+149%) also performed well.🔬 3/7